Donation

Donate
Myeloma Minute
Topics
Join IMF NLB member Beth Faiman for a replay of her Myeloma Action Month Facebook live Q&A

Ask Me Anything Replay: Insights from IMF NLB Member Beth Faiman

March 27, 2024
Facebook Live
What is the significance of mass spectrometry in measuring myeloma protein levels?

What is the significance of mass spectrometry in measuring myeloma protein levels?

March 7, 2024
Ask Dr. Durie
Revised Definition of Free Light Chains in Serum and Light Chain Monoclonal Gammopathy of Undetermined Significance: Results of the Istopmm Study

Iceland’s iStopMM Study Revises Definition of Free Light Chains in Serum and Light Chain Monoclonal Gammopathy of Undetermined Significance (MGUS) 

January 8, 2024
ASH
Ask Me Anything Replay: Exploring Myeloma Research Breakthroughs with Dr. Joseph Mikhael

Ask Me Anything Replay: Exploring Myeloma Research Breakthroughs with Dr. Joseph Mikhael

October 23, 2023
Facebook Live
What is minimal residual disease (MRD)?

What is minimal residual disease (MRD)?

May 4, 2023
Ask Dr. Durie
Dr Saemundur Rognvaldsson ASH abstract on MGUS

Monoclonal Gammopathy of Undetermined Significance (MGUS) with Multiple Paraproteins: Results from iStopMM

February 1, 2023
ASH
Is there a new highly sensitive blood test to detect minimal residual disease?

Is there a new highly sensitive blood test to detect minimal residual disease? 

January 26, 2023
Ask Dr. Durie
Are mass spectrometry and next-generation flow useful tests to evaluate minimal residual disease (MRD)?

Are mass spectrometry and next-generation flow useful tests to evaluate minimal residual disease (MRD)?

January 19, 2023
Ask Dr. Durie
Do patients with MGUS need to have a bone marrow test?

Do patients with MGUS need to have a bone marrow test?

January 12, 2023
Ask Dr. Durie
Dr. Long abstract on MGUS and CKD as part of the iStopMM study

MGUS and Risk of Chronic Kidney Disease: Results of the Population-Based iStopMM Study

January 2, 2023
ASH
Dr. Sigrun Thorsteinsdottir abstract on CTPC and Smoldering Multiple Myeloma

Circulating Tumor Plasma Cells in the Screened iStopMM Smoldering Multiple Myeloma Cohort

January 2, 2023
ASH
Dr. Noemi Puig on NGF vs Mass Spec

Clinical Impact of NGF in Bone Marrow Vs Qip-Mass Spectrometry in Peripheral Blood to Assess MRD in Newly Diagnosed Multiple Myeloma Pts Receiving Maintenance

December 27, 2022
ASH

Give Where Most Needed

Learn More